<DOC>
	<DOCNO>NCT02235493</DOCNO>
	<brief_summary>The purpose study characterize natural history HPP patient Juvenile-onset HPP serve historical control ENB-006-09 .</brief_summary>
	<brief_title>Non-interventional Substudy ALX-HPP-502 Assess Natural History Patients With Juvenile-onset HPP Who Served Historical Controls ENB-006-09</brief_title>
	<detailed_description>Hypophosphatasia ( HPP ) life-threatening , genetic , ultra-rare metabolic disease characterize defective bone mineralization impair phosphate calcium regulation lead progressive damage multiple vital organ , include destruction deformity bone , profound muscle weakness , seizure , impair renal function , respiratory failure . There approve disease-modifying treatment patient disease . There also limit data available natural course disease time , particularly patient juvenile-onset form .</detailed_description>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Hypophosphatasia</mesh_term>
	<criteria>Documented informed consent/assent prior video collection data abstraction . Documented informed consent/assent Study ALXHPP502 . Patients juvenileonset HPP select historicalcontrol Study ENB00609 . Patients least 2 video basic mobility record 2 different clinic visit patient ≥5 ≤15 ye There exclusion criterion study</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>HPP</keyword>
	<keyword>Soft Bones</keyword>
	<keyword>low Alkaline Phosphatase</keyword>
	<keyword>genetic metabolic disorder</keyword>
	<keyword>alkaline phosphatase</keyword>
	<keyword>tissue non-specific alkaline phosphatase</keyword>
	<keyword>rickets</keyword>
	<keyword>osteomalacia</keyword>
</DOC>